Tukysa availability in India | 9310090915

1. Tucatinib (Tukysa) availability in india Tucatinib is an approved FDA-authorized medication used in the treatment of advanced or metastatic HER2-positive breast cancer and RAS wild-type HER2-positive unresectable or metastatic colorectal cancer. This medication is now marketed under the brand name Tukysa. As of now, Tucatinib Tukysa in India is not yet registered, meaning it is not available in regular pharmacies or through general suppliers. However, Indian patients have the option to legally access Tucatinib/Tukysa in India through specialized import channels. These authorized avenues ensure the sourcing and delivery of important medicine in compliance with Indian regulatory guidelines. Tucatinib is typically used in combination with other chemotherapy medicines to enhance treatment effectiveness. In recent years, oncologists in India have increasingly recommended Tucatinib for eligible cancer patients. Tucatinib is manufactured in tablet form and is available in 2 strengths: Tucatinib 50 mg and Tucatinib 100 mg. Patients requiring this treatment should consult their oncologists and reach out to authorized pharmaceutical importers to explore legal procurement options. Availability and Access in India: As of now, Tucatinib is not registered in India and cannot be accessed through routine pharmacies or suppliers. However, patients can access this medication through the Named Patient Program (NPP), which allows for the import of unapproved drugs for personal use under specific conditions. To access Tukysa in India, patients need to:  Obtain a Valid Prescription: A qualified oncologist must prescribe this medicine after evaluating the patient's condition.  Collect Necessary Documentation: This includes the patient's diagnostic reports, tests, and government-issued ID proof.  Contact Authorized Facilitators: Organizations like the Indian Pharma Network (IPN) assist in importing hard-to-access medicines through the NPP. We can be reached at: oEmail: info@indianpharmanetwork.in oPhone: +91 9310090915

2. Trusted facilitators like IPN help ensure compliance with legal requirements and coordinate the import process to provide on-time access to the medicine. Pricing Considerations: based on some factors such as the manufacturer's price, support fees, shipping costs, and applicable taxes. For accurate pricing and availability, patients should contact authorized facilitators directly. For instance, the Indian Pharma Network (IPN) can provide quotes upon request. Potential Side Effects: Common side effects of Tucatinib 50 mg/100 mg may include:  diarrhea  nausea  vomiting  fatigue  liver problems  hand-foot syndrome (redness and swelling of the hands and feet) Patients are advised to report any unusual suspected signs and symptoms to their healthcare provider (HCP) promptly. Final Words: Tucatinib 50 mg/100 mg tablet offers a valuable treatment option for patients with specific types of HER2-positive cancers. While not yet registered in India, patients can access it through provisions like the Named Patient Program (NPP) with the assistance of trusted importers like the Indian Pharma Network (IPN). Patients should consult with their healthcare providers (HCPs) to determine if this oral medicine is relevant to their treatment and follow the necessary steps to access the medication legally and safely. Frequently Asked Questions (FAQs): How can I buy Tukysa in India? To buy Tukysa in India, patients need a valid prescription from their oncologist. Indian Pharma Network (IPN) is a trusted Tukysa importer in India. We ensure legal access and delivery of this oral medication to patients in need. Where can I buy Tukysa 50 MG/100 MG in India? Patients can buy Tukysa 50 MG/100 MG in India through the Indian Pharma Network (IPN), an authorized supplier and importer. IPN ensures the availability of Tukysa by handling import regulations and delivering the medication safely to patients across India. Can I buy Tukysa 50 MG/100 MG in cities? Yes, the Indian Pharma Network (IPN) supplies Tukysa across major cities in India. Patients can buy Tukysa in New Delhi, Lucknow, Noida, Gurgaon, Pune, Mumbai, Ahmedabad, and Bangalore through IPN’s seamless import and delivery services. Who is the leading Tukysa importer in India? Indian Pharma Network (IPN) is a leading Tukysa importer in India. We specialize in sourcing and supplying Tukysa legally. With strong global connections, IPN ensures safe and timely access to Tukysa oral tablets for patients requiring HER2-positive cancer treatment. Where can I find a trusted Tukysa supplier in India?

3. Indian Pharma Network (IPN) is a reputable Tukysa supplier in India. We provide high-quality, legally imported medication sourced from the USA and Europe. IPN works with authorized distributors to ensure patients get genuine Tukysa with proper documentation and adherence to Indian regulatory standards. In which countries has Tukysa (tucatinib) received approval? Tukysa (tucatinib) has received approval from multiple regulatory agencies worldwide for the treatment of advanced HER2-positive breast cancer in combination with trastuzumab and capecitabine. The approvals are as follows:  The Food and Drug Administration (FDA), USA – April 17, 2020  Swissmedic, Switzerland – May 12, 2020  Health Science Authority, Singapore – May 19, 2020  Health Canada, Canada – June 3, 2020  Therapeutic Goods Administration (TGA), Australia – August 12, 2020  The European Medicines Agency (EMA), Europe – February 18, 2021